GSS 0.74% 68.0¢ genetic signatures limited

Ann: First quarter sales update, page-9

  1. 401 Posts.
    lightbulb Created with Sketch. 252
    Precisely. GSS can plausibly aspire to full year revenues of circa $50 million in the current financial year based upon its revenue growth rates. That puts it on a current-year revenue multiple of about 5x. Can a revenue multiple this low be justified for a company growing revenues at 50% (versus the prior quarter that is!) when the revenue base from which such growth rates are being achieved already reflect rapid and even higher revenue growth?

    This is a rapidly growing global business and this is an excellent revenue result.


 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.